Tanshinone IIA Attenuates Interleukin-17A-Induced Systemic Sclerosis Patient-Derived Dermal Vascular Smooth Muscle Cell Activation via Inhibition of the Extracellular Signal-Regulated Kinase Signaling Pathway. Clinics 2015, 70 (4), 250-256. https://doi.org/10.6061/clinics/2015(04)06.